Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

CTMX CytomX Therapeutics Inc

0,8701

0,00 (0,00%)

21 Nov 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

CytomX Therapeutics (NASDAQ:CTMX)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more CytomX Therapeutics Charts.

CytomX Therapeutics (NASDAQ:CTMX)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more CytomX Therapeutics Charts.

News CytomX Therapeutics Inc

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (7 Tage vor) • Edgar (US Regulatory)

CytomX Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Donnerstag 7 November 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 7 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 7 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

CytomX Therapeutics to Report Third Quarter 2024 Financial Results on November 7, 2024
Donnerstag 31 Oktober 2024 (3 Wochen vor) • GlobeNewswire Inc.

CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY®, in a Phase 1 Study in Patients with Solid Tumors
Montag 9 September 2024 (2 Monate vor) • GlobeNewswire Inc.

CytomX Therapeutics to Present at Upcoming September Investor Conferences
Mittwoch 4 September 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 23 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 23 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 22 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 22 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Dienstag 20 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere CytomX Therapeutics Inc News-Artikel

Financial Select Sector

Health Care Select Sector

Deutsche Lufthansa

Invesco QQQ Trust Series 1

Euro vs US Dollar

Deutsche Telekom

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen